Kala Pharmaceuticals

Kala Pharmaceuticals

Kala Pharmaceuticals

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
Founded
2009
Raised
$109.2M
Follow us
Alexa global traffic share
Latest funding Show all
$22,500,000
Venture capital (Series B) - 2014
Polaris Partners Lux Capital Third Rock Ventures +3
Team Size
1–10
Employees
Pulse 2.0

Kala Pharmaceuticals (KALA) Stock: Why The Price Increased 17.01% Today